News Sentiment

ICUI sentiment intelligence

ICU Medical Inc news scored across direct company coverage, industry context, sector read-through, source quality, and freshness.

Chart Weekly report Factors RSS feed
Weighted score 58 Balanced news tone 47 relevant articles
Exchange NASDAQ United States
Sector Healthcare Market context
Industry Medical Instruments & Supplies Read-through group
Latest close 154.42 Week of 10 Jul 2026
Weighted tone 58/100

Balanced news tone

Market reaction Balanced read

News tone and price action are not far from neutral.

Primary event Market update

74/100 classification confidence.

Company focus 47

directly relevant articles

Source quality 2

high-authority source matches

Trend context Trend inactive

-0.4% over one week, +8.6% over four weeks, trend inactive, and near fair-value range.

Latest direct headline Neutral

Analyst Report: ICU Medical, Inc.

Market Reaction

Balanced read

56/100 confidence

News tone and price action are not far from neutral.

Primary event Market update 74/100 classification
One-week reaction -0.4% Price digesting
Trend fit Trend inactive 8.6% over four weeks
Fair value 16.4% Near fair-value range

Sentiment Mix

Positive, neutral, negative

Weighted by relevance
Positive 23
Neutral 21
Negative 3

Relevance

Why the article matched

Direct first
Direct company coverage 47
Industry context 0
Sector context 0

Sources

Coverage mix

Publishers
Market source 10
TradingView 7
simplywall.st 4
Stock Titan 4
Sahm 3
Investing.com Nigeria 2
Investing.com 2
Stock Traders Daily 2

Event Lens

What the news is about

Classified themes
Market update 19
Earnings 14
Analyst action 6
Macro sensitivity 5
Deals and strategy 1
Regulatory and legal 1
Guidance 1

Sentiment Trail

Score over time

50 baseline
Above 50 Neutral zone Below 50

News Tape

Relevant headlines

Showing 1-30 of 47
Morningstar Research Direct company coverage

Analyst Report: ICU Medical, Inc.

Tone
Neutral 50/100
Event
Analyst action
Published
16 Jul 2026 18:36
Source
Morningstar Research
Morningstar Direct company coverage

Improved Focus and More-Profitable Business Mix Narrate No-Moat ICU Medical's Turnaround Story

ICU Medical, originating as an infusion consumables supplier, diversified its product portfolio through key acquisitions, notably Hospira Infusion Systems in 2017 and Smiths Medical in 2022. These strategic moves broadened its offerings to include infusion pumps and IV solutions,

Tone
Positive 73/100
Event
Deals and strategy
Published
16 Jul 2026 18:11
Source
Morningstar
Investing.com Direct company coverage

ICU Medical stock hits 52-week high at 162.53 USD

ICU Medical Inc. (ICUI) stock reached a new 52-week high of $162.18, reflecting a significant 27.93% increase over the past year. InvestingPro analysis suggests the stock is currently undervalued, with a PEG ratio of 0.57, highlighting strong investor confidence and growth potent

Tone
Positive 74/100
Event
Market update
Published
16 Jul 2026 13:42
Source
Investing.com
Community Impact Direct company coverage

Pharmaceutical venture announces $500M expansion in Northwest Austin

Otsuka ICU Medical LLC is investing $500 million to expand its manufacturing facilities in Austin. This expansion includes a new 500,000-square-foot facility and upgrades to its existing 700,000-square-foot site, aiming to improve the long-term supply of IV solutions and support

Tone
Positive 72/100
Event
Macro sensitivity
Published
14 Jul 2026 03:12
Source
Community Impact
MarketBeat Direct company coverage

ICU Medical (ICUI) Short Interest & Short Float | Updated Jul 2026 $ICUI

As of June 30, 2026, ICU Medical (ICUI) had a short interest of 1.69 million shares, marking a 4.94% decrease from the previous report, representing 6.89% of the public float. The short interest ratio is 4.6 days to cover, indicating it would take 4.6 days to cover all short posi

Tone
Positive 61/100
Event
Market update
Published
10 Jul 2026 18:40
Source
MarketBeat
Market source Direct company coverage

Otsuka ICU Medical outlays $500m to expand US manufacturing footprint

Otsuka ICU Medical is investing $500 million to expand its US-based IV manufacturing capabilities, including a new 500,000-square-foot facility and upgrades to an existing 700,000-square-foot site in Austin, Texas. This expansion aims to enhance supply reliability for North Ameri

Tone
Positive 72/100
Event
Macro sensitivity
Published
10 Jul 2026 15:40
Source
Market source
Sahm Direct company coverage

Does ICU Medical’s (ICUI) Russell Index Exit Quietly Reshape Its Institutional Ownership Story?

ICU Medical (ICUI) was removed from several Russell growth and small-cap indexes in June 2026, which may alter trading flows and reshape its institutional ownership. While the core business of infusion therapies remains, the company faces ongoing regulatory risks and product reca

Tone
Negative 36/100
Event
Regulatory and legal
Published
10 Jul 2026 05:41
Source
Sahm
GuruFocus Direct company coverage

ICU Medical Inc (ICUI) Stock Up 3.2% but GF Value Says Overvalued -- GF Score: 80/100

ICU Medical Inc (ICUI) stock rose 3.2% to $156.52, but GuruFocus' GF Value™ indicates it is 30.1% overvalued with an intrinsic value of $120.31. Despite a strong GF Score™ of 80/100, highlighting good profitability and growth, its financial strength and valuation ranks are modera

Tone
Negative 29/100
Event
Market update
Published
09 Jul 2026 23:40
Source
GuruFocus
TradingView Direct company coverage

Otsuka ICU Medical LLC Announces Over $500M Expansion of IV Solutions Manufacturing in North America

Otsuka ICU Medical LLC is investing over $500 million to expand its IV solutions manufacturing in North America, with a new 500,000-square-foot facility and upgrades to existing operations in Austin, Texas. This expansion aims to enhance supply chain resiliency, accelerate the de

Tone
Positive 74/100
Event
Macro sensitivity
Published
09 Jul 2026 16:40
Source
TradingView
www.marketscreener.com Direct company coverage

Otsuka ICU Medical LLC Announces Over $500 Million Expansion Of IV Solutions Manufacturing In North America

Otsuka ICU Medical LLC is investing over $500 million to expand its North American IV solutions manufacturing capabilities, including a new 500,000-square-foot facility in Austin, Texas, and upgrades to existing operations. This expansion aims to enhance supply resiliency, accele

Tone
Positive 71/100
Event
Macro sensitivity
Published
09 Jul 2026 14:10
Source
www.marketscreener.com
Investing.com Direct company coverage

Otsuka ICU Medical announces $500M+ Texas manufacturing expansion

Otsuka ICU Medical LLC is investing over $500 million to expand its manufacturing operations in Austin, Texas, adding a new 500,000-square-foot facility to increase production of intravenous solutions and support non-DEHP IV solution development for North America. This expansion,

Tone
Positive 74/100
Event
Market update
Published
09 Jul 2026 13:10
Source
Investing.com
Stock Titan Direct company coverage

How ICU Medical plans to shore up U.S. IV solution supply

Otsuka ICU Medical LLC, a joint venture involving ICU Medical (Nasdaq: ICUI), announced a $500 million expansion for its IV solutions manufacturing in Austin, Texas. This investment includes a new 500,000-square-foot facility and upgrades to the existing 700,000-square-foot site,

Tone
Positive 73/100
Event
Macro sensitivity
Published
09 Jul 2026 12:10
Source
Stock Titan
Stock Traders Daily Direct company coverage

Responsive Playbooks and the ICUI Inflection

This article analyzes Icu Medical Inc. (NASDAQ: ICUI) with a focus on its near, mid, and long-term sentiment and potential price movements. Utilizing AI models, it outlines distinct trading strategies including position, momentum breakout, and risk hedging, complete with entry zo

Tone
Positive 66/100
Event
Market update
Published
08 Jul 2026 02:24
Source
Stock Traders Daily
Sahm Direct company coverage

Is ICU Medical (ICUI) Undervalued As Russell Index Removal Triggers Rebalancing?

ICU Medical (ICUI) was recently removed from several Russell growth indexes, prompting a re-evaluation of its stock. Despite this, the stock has shown recent firm trading and is considered undervalued by some metrics, with an intrinsic discount and an average analyst price target

Tone
Positive 64/100
Event
Analyst action
Published
06 Jul 2026 16:40
Source
Sahm
Ad-hoc-news.de Direct company coverage

ICU Medical Inc business profile and stock context

ICU Medical Inc is a global medical technology company listed on Nasdaq, specializing in the design, manufacture, and sale of infusion systems and medical devices used in hospitals and clinical settings. The company focuses on improving the safety and efficiency of intravenous th

Tone
Positive 62/100
Event
Market update
Published
03 Jul 2026 20:40
Source
Ad-hoc-news.de
TradingView Direct company coverage

Price to book forward of ICU Medical, Inc. – NASDAQ:ICUI

This article displays the "Price to book forward" financial metric for ICU Medical, Inc. (NASDAQ: ICUI) on TradingView. It presents a value and change percentage for this specific period. The content is primarily a data display page rather than an analytical article.

Tone
Neutral 50/100
Event
Market update
Published
30 Jun 2026 16:13
Source
TradingView
Sahm Direct company coverage

Does ICU Medical’s (ICUI) Russell Growth Exit Hint at a Shifting Long-Term Portfolio Role?

ICU Medical, Inc. (ICUI) was removed from several Russell growth indices in late June 2026, which could impact its trading volume and portfolio positioning for growth-focused funds. While this creates short-term noise, the company's investment narrative still centers on long-term

Tone
Negative 40/100
Event
Market update
Published
30 Jun 2026 16:13
Source
Sahm
TradingView Direct company coverage

Price to sales forward of ICU Medical, Inc. – NASDAQ:ICUI

This article displays the forward price-to-sales ratio for ICU Medical, Inc. (NASDAQ: ICUI). It presents the current value and its change over a period, accessible through TradingView. The content primarily focuses on financial data for the company.

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 19:10
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of ICU Medical, Inc. – NASDAQ:ICUI

This article provides the forward price-to-earnings ratio for ICU Medical, Inc. (NASDAQ: ICUI). It is presented as part of a financial overview on TradingView, indicating the company's valuation based on future earnings estimates. The content itself is very brief, showing "Period

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 10:10
Source
TradingView
TradingView Direct company coverage

Price to earnings forward of ICU Medical, Inc. – DUS:IC7

This article provides financial data for ICU Medical, Inc. under the stock symbol IC7 on the Dusseldorf Stock Exchange. It specifically highlights the "Price to earnings forward" metric. The page is part of a larger financial data platform by TradingView.

Tone
Neutral 50/100
Event
Earnings
Published
27 Jun 2026 08:40
Source
TradingView
TradingView Direct company coverage

Enterprise value to EBITDA forward of ICU Medical, Inc. – NASDAQ:ICUI

This article provides the enterprise value to EBITDA forward for ICU Medical, Inc. (NASDAQ: ICUI). It appears to be a financial data point from TradingView, indicating a specific valuation metric for the company. The page focuses on the financial data rather than providing a deta

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 06:40
Source
TradingView
Stock Traders Daily Direct company coverage

Understanding the Setup: (ICUI) and Scalable Risk

Icu Medical Inc. (NASDAQ: ICUI) is exhibiting a mid-channel oscillation pattern with strong near and mid-term sentiment that could extend long-term. An exceptional 35.6:1 risk-reward short setup targets a 10.4% downside with only 0.3% risk. AI models have generated distinct tradi

Tone
Neutral 50/100
Event
Market update
Published
27 Jun 2026 01:40
Source
Stock Traders Daily
TradingView Direct company coverage

ICUI Forecast — Price Target — Prediction for 2027

This article provides a forecast and price target for ICU Medical, Inc. (ICUI), detailing analyst opinions, historical stock performance, and key financial metrics. It highlights the current stock price, volatility, market capitalization, and upcoming earnings report, along with

Tone
Positive 66/100
Event
Analyst action
Published
26 Jun 2026 12:39
Source
TradingView
Moomoo Direct company coverage

ICU Medical (ICUI) Stock Forum and Discussion

This document appears to be a stub or an empty placeholder for a stock forum and discussion about ICU Medical (ICUI). There is no actual content provided beyond the title. The purpose is likely to host future discussions or information related to ICUI stock.

Tone
Neutral 50/100
Event
Market update
Published
25 Jun 2026 13:10
Source
Moomoo
Investing.com Nigeria Direct company coverage

Moody’s upgrades ICU Medical rating to Ba3 on leverage outlook By Investing.com

Moody's Ratings has upgraded ICU Medical, Inc. (NASDAQ:ICUI) to Ba3 from B1, anticipating a decline in the company's financial leverage over the next 12 months. This upgrade is based on expectations of adjusted debt to EBITDA remaining below 4.0x, driven by revenue growth, strong

Tone
Positive 71/100
Event
Analyst action
Published
17 Jun 2026 20:50
Source
Investing.com Nigeria